-
Why autism affects more men than women—MDGA1 gene mutation may help explain
Researchers have discovered that a mutation of the MDGA1 gene, a key factor modulating the connections and characteristics between nerve... Read more -
How the blood-brain barrier opens: Two proteins may guide future drug delivery
The cells that line the blood vessels in our brains are highly selective. By deciding which molecules are allowed in... Read more -
Without the right tests, the best medicines make no difference
A new analysis from UC San Francisco argues that diagnostics—medical tests that match patients to the appropriate treatment—are being overlooked... Read more -
Flu treatment shields lungs, cuts pneumonia risk
A new flu treatment could drastically reduce one of flu's deadliest complications—bacterial pneumonia—by helping the lungs defend themselves, rather than... Read more -
Psilocybin mushrooms are going mainstream, but scientific research and regulation lag behind
Amid a renaissance in the science of psychedelics, public interest in psilocybin—or magic mushrooms, as they've long been known—is surging.... Read more -
AAD: Subcutaneous amlitelimab aids atopic dermatitis outcomes through week 24
Amlitelimab, a fully human non-T cell depleting monoclonal antibody that selectively targets OX40-ligand (OX40L), is safe and effective, with potentially... Read more -
Antibody drugs with strong immune cell binding linked to allergic reactions
Antibody therapeutics are laboratory-made proteins designed to work like the body's natural antibodies. They are widely used to treat diseases... Read more -
Parkinson's add-on drugs may spur gut bacteria that break down levodopa, study finds
Levodopa—the gold-standard treatment for Parkinson's disease—increases dopamine in the brain. But as the disease progresses in severity, patients often need... Read more -
Long-term opioid prescribing has fallen, but millions still receive extended opioid therapy
Long-term opioid prescribing has fallen in the United States over the last decade, but millions of patients still received opioids... Read more -
Genetic predictors for GLP-1 weight loss efficacy and side effects identified
23andMe Research Institute, a nonprofit medical research organization, announced the publication of a study that identifies genetic predictors for GLP-1... Read more -
Some common IBS treatments are linked to a higher risk of death, say study
A large, long-term study led by Cedars-Sinai Health Sciences University investigators suggests that some medications commonly prescribed to treat irritable... Read more -
Molecular map could unlock new treatments for heart and lung diseases
Scientists have created a new "molecular map" uncovering how an important human receptor involved in blood clotting and inflammation works—an... Read more -
Treating tumors independently of oxygen: Photodynamic therapy uses hydrogen peroxide instead
Photodynamic treatment of cancer is based on administering an initially inactive substance that is only activated in the tumor via... Read more -
Massive eye drop recall reflects ongoing issues with manufacturing and FDA inspection
A California company has recalled more than 3.1 million bottles of lubricating eye drops because it had not properly tested—and... Read more -
Can medicinal cannabis help kids' autism, ADHD or Tourette's? Here's what we know so far
In the past 10 years or so, there has been a lot of interest to see if medicinal cannabis can... Read more
